LEXISNEXIS LIFE SCIENCES SOLUTIONS
Understanding UDI Series
Gain answers to your questions about Unique Device Identification (UDI). Book time with a UDI expert for in-depth Q&A plus access to a library of tutorials and reference materials
Australia TGA/AusUDID
Australia’s Therapeutic Goods Administration (TGA) is advancing its Unique Device Identification system (AusUDID), bringing the country further into alignment with global UDI standards. With phased implementation beginning in the coming years, medical device manufacturers must prepare for new data submission, labeling, and ongoing compliance requirements.
Australia’s approach reflects global harmonization efforts, aligning with established UDI frameworks such as the FDA and elements of EUDAMED. For manufacturers operating internationally, this creates both opportunity and complexity — requiring coordinated data management across multiple regulatory systems.
LexisNexis Life Sciences simplifies that complexity. We support manufacturers across the entire product lifecycle — from initial market entry and UDI data preparation to ongoing updates, change management, and post-market compliance. Our global regulatory expertise and technology-driven solutions help ensure your device data stays accurate, synchronized, and inspection-ready, so you can focus on innovation while we help safeguard compliance.
Timeline
Related Resources
The State of Global Regulatory Compliance 2026
Global authorities are accelerating UDI expansion and modernizing submission frameworks worldwide. Life sciences organizations must strengthen data governance while adapting to evolving regulatory expectations. Explore the key trends shaping compliance in 2026.
Behind-the-Scenes: Australia Regulatory Device Summit
Gain exclusive insights from Australia’s leading regulatory device summit. Discover how expectations are shifting, where submissions face delays, and what quality evidence regulators prioritize. Learn what your team should focus on to stay ahead in a changing landscape.
Navigating the TGA’s Phased Introduction
Australia’s Therapeutic Goods Administration (TGA) is rolling out a phased regulatory compliance framework. Higher-risk devices are prioritized first, with requirements expanding to lower-risk categories over time.
Understanding UDI
Unique Device Identification (UDI) requirements vary by country and regulatory authority. Select a health authority below to access jurisdiction-specific guidance and resources.
USA
EUROPEAN UNION
CHINA
SOUTH KOREA
AUSTRALIA
SWITZERLAND
Need Guidance on UDI Compliance?
Understanding UDI obligations across global health authorities can be complex. Whether you are preparing for initial submission, managing product data updates, or aligning compliance across multiple markets, our regulatory experts provide practical guidance tailored to your organization’s needs.
